Maimaiti Ailifeire, Li Yang, Wang Yong-Tao, Yang Xiang, Li Xiao-Mei, Yang Yi-Ning, Ma Yi-Tong
Department of Cardiology, First Affiliated Hospital of Xinjiang Medical University, Urumqi, China.
Department of Cardiology, First Affiliated Hospital of Xinjiang Medical University, Urumqi, China
BMJ Open. 2019 Sep 18;9(9):e025628. doi: 10.1136/bmjopen-2018-025628.
Insufficient myocardial reperfusion for patients with acute myocardial infarction (AMI) during primary percutaneous coronary intervention (PPCI) has a great influence on prognosis. The aim of this study was to investigate the association of the platelet-to-lymphocyte ratio (PLR) with myocardial reperfusion and in-hospital major adverse cardiac events (MACEs) in patients with AMI undergoing PPCI.
Retrospective cohort study.
Patients and researchers from two tertiary hospitals.
A total of 445 consecutive AMI patients who underwent PPCI between January 2015 and December 2017 were enrolled. Patients were divided into two groups based on the PLR value: patients with PLR values in the third tertile were defined as the high-PLR group (n=150), and those in the lower two tertiles were defined as the low-PLR group (n=295). Explicit criteria for inclusion and exclusion were applied.
No interventions.
Primary outcome measures were defined as cardiovascular death, reinfarction or target vessel revascularisation. Secondary outcome measures were defined as stroke, non-lethal myocardial infarction, ventricular tachycardia/ventricular fibrillation and in-hospital mortality.
The high-PLR group had insufficient myocardial perfusion (23% vs 13%, p=0.003), greater postprocedural thrombolysis in myocardial infarction flow grade (0-2) (17% vs 10%, p=0.037), greater myocardial blush grade (0-1) (11% vs 4%, p=0.007) and higher B-type natriuretic peptide (BNP) (614±600 vs 316±429, p<0.001) compared with the low-PLR group. Multivariate logistic regression analysis indicated that the independent risk factors for impaired myocardial perfusion were high PLR (OR 1.256, 95% CI 1.003 to 1.579, p=0.056) and high BNP (OR 1.328, 95% CI 1.056 to 1.670, p=0.015). The high-PLR group had significantly more MACEs (43% vs 32%, p=0.029).
This study suggested that high PLR and BNP were independent risk factors for insufficient myocardial reperfusion in patients with AMI. Higher PLR was related to advanced heart failure and in-hospital MACEs in patients with AMI undergoing PPCI.
急性心肌梗死(AMI)患者在直接经皮冠状动脉介入治疗(PPCI)期间心肌再灌注不足对预后有重大影响。本研究旨在探讨血小板与淋巴细胞比值(PLR)与接受PPCI的AMI患者心肌再灌注及院内主要不良心脏事件(MACE)之间的关联。
回顾性队列研究。
两家三级医院的患者和研究人员。
纳入2015年1月至2017年12月期间连续接受PPCI的445例AMI患者。根据PLR值将患者分为两组:PLR值处于第三个三分位数的患者定义为高PLR组(n = 150),处于较低两个三分位数的患者定义为低PLR组(n = 295)。应用明确的纳入和排除标准。
无干预措施。
主要结局指标定义为心血管死亡、再梗死或靶血管血运重建。次要结局指标定义为中风、非致命性心肌梗死、室性心动过速/心室颤动和院内死亡率。
与低PLR组相比,高PLR组心肌灌注不足(23%对13%,p = 0.003),术后心肌梗死溶栓血流分级(0 - 2级)更高(17%对10%,p = 0.037),心肌 blush分级(0 -